This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Yamanashi University. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2012
Title: Innovations by Atsuhito Nakao in Allergy Treatment
Introduction
Atsuhito Nakao is a prominent inventor based in Yamanashi, Japan. He has made significant contributions to the field of allergy treatment through his innovative research and patents. His work focuses on methods that provide effective solutions for allergy prevention and treatment.
Latest Patents
Atsuhito Nakao holds three patents, with his latest inventions centered around the use of transforming growth factor-beta (TGF-β) in treating allergies. One of his notable patents describes a method of treating allergies using TGF-β1 and allergens. This invention outlines an allergy prevention method that allows for the oral administration of TGF-β, enabling the selective suppression of the Th2 immune response. The method aims to prevent allergic symptoms without the adverse reactions associated with traditional administration methods.
Career Highlights
Atsuhito Nakao is affiliated with Yamanashi University, where he conducts research and develops innovative treatments for allergies. His work has garnered attention for its potential to improve the quality of life for individuals suffering from allergic conditions.
Conclusion
Atsuhito Nakao's contributions to allergy treatment through his innovative patents highlight the importance of research in developing effective medical solutions. His work continues to pave the way for advancements in allergy prevention and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile